Latest News
FDA approves Merck's KEYTRUDA or KEYTRUDA QLEX in combination with WELIREG for the adjuvant treatment of adult patients with renal cell carcinoma
Details >FDA approves Sanofi’s subcutaneous Sarclisa Escena anticancer treatment administered via on-body injector.
Details >FDA grants traditional approval to selpercatinib (Retevmo) for locally advanced or metastatic RET fusion-positive solid tumors
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
